Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen
Authors:
- Nadeem A SheikhNSNadeem A Sheikh
- Michael R HollingdaleMHMichael R Hollingdale
- W.JOhn W MorrowWMW.JOhn W Morrow
- Andrew W Taylor-RobinsonAndrew W Taylor-Robinson
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Immune Responses to Liver-Stage Parasites: Implications for Vaccine Development2002
- Vaccination against malaria: targets, strategies and potentiation of immunity to blood stage parasitesFrontiers in Bioscience-Landmark, 2000
- Lipopeptide immunization without adjuvant induces potent and long‐lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzeesEuropean Journal of Immunology, 1997
- Elimination of P. berghei liver stages is independent of Fas (CD95/Apo‐I) or perforin‐mediated cytotoxicityParasite Immunology, 1997
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- Glycoalkaloids selectively permeabilize cholesterol containing biomembranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Molecular basis of glycoalkaloid induced membrane disruptionBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccineMolecular Immunology, 1994
- Th1 and Th2 CD4+ T cell clones specific forPlasmodium chabaudi but not for an unrelated antigen protect against blood stageP. chabaudi infectionEuropean Journal of Immunology, 1994
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991